Nancy Hunter

Scriptyx works to solve healthcare inequity in rural settings where access to quality healthcare can be limited. It's essential to address the issue of treatment access to improve health outcomes and reduce health disparities in these settings.

Endpoint is pioneering a new category of precision medicine while rewriting the molecule-first drug development model. Pipeline focus is on immune driven critical and chronic illnesses. - Partnering with Development team on Phase 2 trials to develop and deliver global strategies and plans that maximize asset value; commercial member of Global Product Team. - Strategic Alliance Management lead; managing multi-country alliance and fulfillment of deal terms via quarterly meetings and internal stakeholder meetings (three subcommittees). - Business development support; identifying partners to support in-licensing and early pipeline assets beyond Sepsis and ARDS to develop emerging commercial therapeutic area strategies. -Developing forecasting model to inform business decision and portfolio prioritization, building integrated intelligence capabilities (Veeva, CRM); defining and writing all commercially related processes and procedures.